| Ytd | -46.85% | |
| 1y | -36.57% |
| Open | 25.12 | Prev Close | 25.35 | Low | 24.46 | High | 25.39 | Mkt Cap | 762.89M |
| Vol | 1.04M | Avg Vol | 558.21K | EPS | 1.27 | P/E | 19.38 | Forward P/E | 4.86 |
| Beta | 0.73 | Short Ratio | 11.92 | Inst. Own | 128.23% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 32.89 | 200-d Avg | 38.60 | 1yr Est | 53.60 |
Freestone Grove Partners LP bought a new stake in shares of Collegium Pharmaceutical, Inc. (NASDAQ:
BlackRock Inc. bought a new position in Collegium Pharmaceutical, Inc. (NASDAQ: COLL) during the und
On August 27, 2026, Collegium Pharmaceutical Inc (COLL) shares fell 3.9% to a current price of $26.3
Barclays analyst Glen Santangelo maintains Collegium Pharmaceutical (NASDAQ:COLL) with a Overweig
STOUGHTON, Mass., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a
Collegium Pharmaceutical (NASDAQ: COLL - Get Free Report) and Avenue Therapeutics (NASDAQ: ATXI - Ge
Piper Sandler analyst David Amsellem reiterates Collegium Pharmaceutical (NASDAQ:COLL) with a Neu
Collegium Pharmaceutical, Inc. (COLL) Q2 2026 Earnings Call Transcript
Needham analyst Serge Belanger maintains Collegium Pharmaceutical (NASDAQ:COLL) with a Buy and lo
Although the revenue and EPS for Collegium Pharmaceutical (COLL) give a sense of how its business pe
Collegium Pharmaceutical (COLL) came out with quarterly earnings of $1.92 per share, beating the Zac
Collegium Pharmaceutical NASDAQ: COLL reported second-quarter 2026 net product revenue of $199.9 mil
Collegium Pharmaceutical (NASDAQ:COLL) lowers FY2026 sales outlook from $865.000 million-$895.000 mi
– Completed Acquisition of AZSTARYS ® , Strengthening ADHD Portfolio and Extending Long-Term Revenue
Collegium Pharmaceutical (COLL) is transitioning from a pain-management roll-up to a CNS platform, l
STOUGHTON, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a
Bessemer Group Inc. grew its stake in shares of Collegium Pharmaceutical, Inc. (NASDAQ: COLL) by 48.
BOSTON--(BUSINESS WIRE)--DivcoWest, a DivCore Capital company and national commercial real estate in
STOUGHTON, Mass., July 20, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) a
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and
COLL, IRWD, AMTB and DUK stand out as defensive stock picks as investors rotate from AI-driven tech
BBCP, KUBTY, ADM, COLL and W have been added to the Zacks Rank #1 (Strong Buy) List on July 6, 2026.
COLL gains momentum as strong Jornay PM growth and the Azstarys acquisition boosted 2026 guidance, s
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and
Collegium Pharmaceutical (NASDAQ:COLL) affirms FY2026 sales outlook from $805.000 million-$825.000 m
Collegium Pharmaceutical (NASDAQ:COLL) reported quarterly earnings of $1.76 per share which beat the
HC Wainwright & Co. analyst Brandon Folkes reiterates Collegium Pharmaceutical (NASDAQ:COLL)
– Adds Highly Complementary and Differentiated Medicine with Significant Growth Potential to Collegi
Needham analyst Serge Belanger maintains Collegium Pharmaceutical (NASDAQ:COLL) with a Buy and lo
Collegium Pharmaceutical (NASDAQ:COLL) sees FY2026 sales of $805.000 million-$825.000 million vs $80
Collegium Pharmaceutical (NASDAQ:COLL) reported quarterly earnings of $2.04 per share which missed t
Barclays analyst Glen Santangelo maintains Collegium Pharmaceutical (NASDAQ:COLL) with a Overweig
HC Wainwright & Co. analyst Brandon Folkes reiterates Collegium Pharmaceutical (NASDAQ:COLL)
Needham analyst Serge Belanger maintains Collegium Pharmaceutical (NASDAQ:COLL) with a Buy and ra
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Friday. Here are some big
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss a
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnin
Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnin